JUL 05, 2018 6:21 AM PDT

Stem Cell Treatment Restores Failing Macaque Monkey Hearts

WRITTEN BY: Kara Marker

A new way to prevent heart attack from turning into heart failure relies on heart cells made from human embryonic stem cells. For now, researchers are testing the treatment in macaque monkeys, whose hearts are similar to human hearts in size and function.

Stem cell-derived human cardiomyocytes (green) integrated into the scarred area (blue) of a heart wall (red). Credit: Xiulan Yang/Murry Lab

The next step? Use the same approach to treat human heart failure, the leading cause of death for both men and women worldwide. Nearly seven million Americans are currently living with heart failure.

In humans, heart tissue damaged by heart disease does not regenerate. Instead, it is replaced with scar tissue cells, called fibroblasts. Scientists have long been researching stem cells and regenerative organisms like zebrafish, looking for a way to make new human heart muscle cells (cardiomyocytes) as a way to better treat heart disease.

"Our findings show that human embryonic stem cell-derived cardiomyocytes can re-muscularize infarcts in macaque monkey hearts and, in doing so, reduce scar size and restore a significant amount of heart function," explained senior project leader Charles Murry. "This should give hope to people with heart disease."

The study began with induced heart attacks in macaque monkeys, effectively reducing their left ventricular ejection fraction (LVEF) to cause heart failure. LVEF describes how much blood the heart can pump out with each heartbeat. After the experimental heart attacks, the monkeys’ LVEF decreased from 65 percent to 40 percent.

Two weeks later, researchers injected heart cells grown from human embryonic stem cells into the scar tissue of an experimental group of failing monkey hearts, with each receiving nearly 750 million cells. A control group received the solution the heart cells were in but not the cells themselves.

Four weeks after treatment, LVEF improved and continued to improve in the experimental group but not in the control group, and MRI scans showed that new heart muscle had grown in the experimental group.

The heart cells derived from human embryonic stem cells had formed new muscle tissue in the area of the heart damaged by the induced heart attack, mixing in with the natural, surrounding healthy tissue and replacing 10-29 percent of the scar tissue.

The ideal for the future is that, based on these findings, researchers can develop a one-time only treatment that could be given to people quickly after a heart attack to prevent heart failure.

The present study was published in the journal Nature Biotechnology.

Source: University of Washington Health Sciences/UW Medicine

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 22, 2020
Cardiology
Can Playing Your Favorite Music Improve Your Physical Performance?
AUG 22, 2020
Can Playing Your Favorite Music Improve Your Physical Performance?
If you go to the gym, you will usually see people with headphones jamming out to their favorite music while exercising. ...
SEP 16, 2020
Cardiology
Stem Cells Can Generate a 3D Mini-Model of the Heart
SEP 16, 2020
Stem Cells Can Generate a 3D Mini-Model of the Heart
The heart is a special organ, and while we know a lot about how it develops, there are still mysteries.
OCT 06, 2020
Cardiology
A New Heart Drug Taken from a Yellow Dye
OCT 06, 2020
A New Heart Drug Taken from a Yellow Dye
Cardiovascular disease is an ever-present issue in the modern world.  One of the most unfortunate cardiovascular ev ...
OCT 13, 2020
Cardiology
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
OCT 13, 2020
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
Biomarkers have taken the diagnostic field by storm over the past decade. The search for stable, easy to access indicato ...
DEC 13, 2020
Cardiology
Potential Treatment for Common Cause of Heart Disease is ID'ed
DEC 13, 2020
Potential Treatment for Common Cause of Heart Disease is ID'ed
The most common cause of heart disease in elderly people is calcific aortic valve disease, in which calcium builds up in ...
JAN 19, 2021
Cardiology
Risk of Atrial Fibrillation Raised by Daily Alcoholic Drink
JAN 19, 2021
Risk of Atrial Fibrillation Raised by Daily Alcoholic Drink
Some studies have suggested that moderate alcohol intake is linked to a lower risk of death from heart disease. But that ...
Loading Comments...